COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was declared a global pandemic by the World Health Organization (WHO). The clinical course of the disease is unpredictable but may lead to severe acute respiratory infection (SARI) and pneumonia leading to acute respiratory dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotfis, Katarzyna, Lechowicz, Kacper, Drożdżal, Sylwester, Niedźwiedzka-Rystwej, Paulina, Wojdacz, Tomasz K., Grywalska, Ewelina, Biernawska, Jowita, Wiśniewska, Magda, Parczewski, Miłosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830835/
https://www.ncbi.nlm.nih.gov/pubmed/33477294
http://dx.doi.org/10.3390/ph14010071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830835/
https://www.ncbi.nlm.nih.gov/pubmed/33477294
http://dx.doi.org/10.3390/ph14010071

Ejemplares similares